MannKind Announces CFO Transition
Mr. Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.
- Mr. Binder plans to remain at MannKind through the end of the year as Executive Vice President, Special Projects.
- “We are excited to have Chris join us at such a pivotal time as our new CFO,” said Michael Castagna, PharmD., Chief Executive Officer for MannKind Corporation.
- We are pleased that Steve will remain with MannKind for the rest of 2024, allowing for an optimal transition with Chris.”
“I look forward to working with Chris and remain totally committed to MannKind’s continued success,” said Steve Binder, Chief Financial Officer. - His earlier career also included senior financial roles at InterMune, Inc., Dynavax Technologies Corporation and MannKind.